Breast cancers exhibiting BRCA gene mutation are predominantly basal-type ER-negative, HER2 overexpressed, and triple-negative breast cancers (TNBCs) [48,49]. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.